Calamos Advisors’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$623K Buy
46,173
+12,774
+38% +$172K ﹤0.01% 689
2025
Q1
$289K Buy
+33,399
New +$289K ﹤0.01% 728
2022
Q3
Sell
-89,362
Closed -$2.45M 1294
2022
Q2
$2.45M Buy
89,362
+16,914
+23% +$463K 0.01% 850
2022
Q1
$2.73M Sell
72,448
-19,093
-21% -$720K 0.01% 841
2021
Q4
$5.69M Sell
91,541
-25,299
-22% -$1.57M 0.02% 622
2021
Q3
$10M Buy
116,840
+31,390
+37% +$2.69M 0.04% 400
2021
Q2
$5.29M Sell
85,450
-13,877
-14% -$859K 0.02% 515
2021
Q1
$4.84M Buy
99,327
+32,049
+48% +$1.56M 0.03% 518
2020
Q4
$2.1M Buy
67,278
+27,618
+70% +$860K 0.01% 599
2020
Q3
$827K Buy
+39,660
New +$827K 0.01% 641
2020
Q1
Sell
-163,600
Closed -$1.68M 751
2019
Q4
$1.68M Sell
163,600
-149,164
-48% -$1.53M 0.01% 592
2019
Q3
$4.53M Buy
312,764
+45,548
+17% +$660K 0.02% 498
2019
Q2
$4.33M Buy
+267,216
New +$4.33M 0.02% 518